Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260585 · ClinicalTrials.gov registry record
Esophageal Cancer Risk Registry
A clinical trial of Esophageal Cancer and Hiatal Hernia, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 7,000
- Enrollment target
- 1
- Study location
NCT00260585: Recruiting study of Esophageal Cancer and Hiatal Hernia, sponsored by University of Pittsburgh.
NCT00260585 is a study of Esophageal Cancer and Hiatal Hernia that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 7,000 participants, above the 442-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (1484% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260585, a study of Esophageal Cancer and Hiatal Hernia, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 7,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical history, blood, and tissue samples from patients who present with an esophageal disorder. Identifying genetic and behavioral risk factors involved in the development of esophageal cancer might allow for early detection and prevention. Survival and an opportunity for a cure with esophageal cancer will depend greatly on the stage of diagnosis. Tumors can develop changes in their genetic (hereditary) make-up, and these changes can sometimes be seen in normal tissues before the development of cancer. These genetic (hereditary) changes can serve as tumor markers and can be detected using methods that study changes in genetic material like DNA and RNA. The analysis of proteins can provide additional information. By identifying changes in these molecules that are different or altered in cancer, the investigators can use methods and tests for the detection of these changes.
Conditions Studied
Interventions
- PROCEDURE Survey of client health, personal habits, family history
- PROCEDURE Blood specimen for non-DNA and DNA parts
- PROCEDURE Biopsy of esophageal/stomach tissue, lymph nodes, tumor
- PROCEDURE Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
Study Locations (1)
Pennsylvania
- Department of Cardiothoracic Surgery - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,000 participants |
| Start Date | 1999-06 |
| Est. Completion | 2050-12 |
What NCT00260585 shows while recruiting
NCT00260585 is an observational study that tracks outcomes without assigning an intervention. Its 7,000 participants enrollment target places it among the larger protocols in the corpus, above the 442-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (1484% higher).
The record links to 5 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 4 interventions - of which Survey of client health, personal habits, family history is the first listed.
NCT00260585 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00260585 about?
NCT00260585 is a clinical study titled "Esophageal Cancer Risk Registry". The purpose of this study is to identify markers in the blood and tissue that could indicate risk factors for the development and progression of esophagus cancer. This research aims to collect medical history, blood, and tissue samples from patients who present with an esophageal disorder. Identifyi...
What is the current status of trial NCT00260585?
This trial is currently recruiting. The enrollment target is 7,000 participants. The study started on 1999-06. Estimated completion is 2050-12.
What conditions does trial NCT00260585 study?
This clinical trial studies the following conditions: Esophageal Cancer, Hiatal Hernia, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Esophageal Achalasia.
What interventions are being tested in trial NCT00260585?
The interventions under investigation include: Survey of client health, personal habits, family history (PROCEDURE), Blood specimen for non-DNA and DNA parts (PROCEDURE), Biopsy of esophageal/stomach tissue, lymph nodes, tumor (PROCEDURE), Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies (PROCEDURE).
Who is sponsoring clinical trial NCT00260585?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00260585 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00260585's enrollment target sits among peer trials
7,000 1st of 123 the highest of 123 other Esophageal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Esophageal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
-
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia